Author/Authors :
-، - نويسنده Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Banihashem, Abdollah , -، - نويسنده Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Farhangi, Hamid , -، - نويسنده Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Mousavi Bazaz, Mojtaba , -، - نويسنده Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Badiee, Zahra , -، - نويسنده Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Ghasemi, Ali , -، - نويسنده Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Hesari, Sara
Abstract :
Different therapeutic options in children with immune thrombocytopenic purpura include observation alone, periodic treatment with corticosteroids, intravenous immunoglobulin (IVIG) or anti-D, chronic administration of immunosuppressive agents, and splenectomy.Preference of the type of therapy depends on the degree of thrombocytopenia and clinical bleeding manifestations. Dexamethasone is safe but its side effects are the main disadvantages for its usage. Anti-D is more expensive than dexamethason but the side effect is rare and not dangerous and response to treatment is assessed in approximately 3 days after infusion.
